Chakradhara Rao S. Uppugunduri

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2C19</i> and Proton Pump Inhibitor Dosing

John J. Lima, Cameron D. Thomas, Julia M. Barbarino et al. · Clinical Pharmacology & Therapeutics · 2020 · 298 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study

Marc Ansari, Patricia Huezo-Diaz Curtis, Chakradhara Rao S. Uppugunduri et al. · Oncotarget · 2017 · 68 citations · Full text

Medicine, Hematology, Pharmacology +8

Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients

Marc Ansari, Mohamed Aziz Rezgui, Yves Théorêt et al. · Bone Marrow Transplantation · 2013 · 50 citations

Medicine, Hematology, Pharmacokinetics +15

A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry

Marc Ansari, Chakradhara Rao S. Uppugunduri, Julien Déglon et al. · Rapid Communications in Mass Spectrometry · 2012 · 44 citations · Full text

Pharmacy, Hematology, Pharmacology +17

The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation

Chakradhara Rao S. Uppugunduri, Mohamed Aziz Rezgui, Patricia Huezo Diaz et al. · The Pharmacogenomics Journal · 2013 · 42 citations · Full text

Medicine, Pediatrics, Pharmacology +17